101 related articles for article (PubMed ID: 7220406)
1. Plasma and salivary concentrations of erythromycin after administration of three different formulations.
Henry J; Turner P; Garland M; Esmieu F
Postgrad Med J; 1980 Oct; 56(660):707-10. PubMed ID: 7220406
[TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of two erythromycin esters in plasma and in saliva following oral administration in humans.
Ducci M; Scalori V; del Tacca M; Soldani G; Bernardini C; Grothe E; Bertelli A
Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):494-7. PubMed ID: 7298242
[TBL] [Abstract][Full Text] [Related]
3. Plasma levels following single and repeated doses of erythromycin estolate and erythromycin stearate.
Welling PG; Elliott RL; Pitterle ME; Corrick-West HP; Lyons LL
J Pharm Sci; 1979 Feb; 68(2):150-5. PubMed ID: 423080
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of erythromycin ethylsuccinate and estolate in infants under 4 months of age.
Patamasucon P; Kaojarern S; Kusmiesz H; Nelson JD
Antimicrob Agents Chemother; 1981 May; 19(5):736-9. PubMed ID: 6975059
[TBL] [Abstract][Full Text] [Related]
5. Comparative bioavailability evaluation of erythromycin base and its salts and esters. I. Erythromycin estolate capsules versus enteric-coated erythromycin base tablets.
DiSanto AR; Tserng KY; Chodos DJ; DeSante KA; Albert KS; Wagner JG
J Clin Pharmacol; 1980 Jul; 20(7):437-43. PubMed ID: 7430412
[TBL] [Abstract][Full Text] [Related]
6. Pharmacology of erythromycin in infants and children.
Ginsburg CM
Pediatr Infect Dis; 1986; 5(1):124-9. PubMed ID: 3753798
[No Abstract] [Full Text] [Related]
7. Plasma and saliva concentrations for a new formulation of erythromycin stearate.
Berend N; Rutland J; Marlin GE
Curr Med Res Opin; 1979; 6(2):118-23. PubMed ID: 467089
[TBL] [Abstract][Full Text] [Related]
8. Absorption of erythromycin. A cross-over study in healthy volunteers.
Männistö P; Tuomisto J; Räsänen R
Arzneimittelforschung; 1975 Nov; 25(11):1828-31. PubMed ID: 1106445
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals.
Lakritz J; Wilson WD; Marsh AE; Mihalyi JE
Am J Vet Res; 2000 Aug; 61(8):914-9. PubMed ID: 10951982
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetic advantages of erythromycin estolate over ethylsuccinate as determined by high-pressure liquid chromatography.
Croteau D; Bergeron MG; LeBel M
Antimicrob Agents Chemother; 1988 Apr; 32(4):561-5. PubMed ID: 3259856
[TBL] [Abstract][Full Text] [Related]
11. Comparison of oral erythromycin formulations in the horse using pharmacokinetic profiles.
Ewing PJ; Burrows G; MacAllister C; Clarke C
J Vet Pharmacol Ther; 1994 Feb; 17(1):17-23. PubMed ID: 8196089
[TBL] [Abstract][Full Text] [Related]
12. Effect of food on absorption of erythromycin. A study of two derivatives, the stearate and the base.
Malmborg AS
J Antimicrob Chemother; 1979 Sep; 5(5):591-9. PubMed ID: 500517
[TBL] [Abstract][Full Text] [Related]
13. Bioavailability and effect of food on the gastrointestinal absorption of two erythromycin derivatives.
Mäntylä R; Ailio A; Allonen H; Kanto J
Ann Clin Res; 1978 Oct; 10(5):258-62. PubMed ID: 367255
[TBL] [Abstract][Full Text] [Related]
14. Pharmacology of erythromycin in adults.
Griffith RS
Pediatr Infect Dis; 1986; 5(1):130-40. PubMed ID: 3511455
[No Abstract] [Full Text] [Related]
15. High-performance liquid chromatographic assay of erythromycin and its esters using electrochemical detection.
Croteau D; Vallée F; Bergeron MG; LeBel M
J Chromatogr; 1987 Aug; 419():205-12. PubMed ID: 3499443
[TBL] [Abstract][Full Text] [Related]
16. Comparative pharmacology of josamycin and erythromycin stearate.
Strausbaugh LJ; Bolton WK; Dilworth JA; Guerrant RL; Sande MA
Antimicrob Agents Chemother; 1976 Sep; 10(3):450-6. PubMed ID: 984786
[TBL] [Abstract][Full Text] [Related]
17. Concentrations of erythromycin in serum and tonsil: comparison of the estolate and ethyl succinate suspensions.
Ginsburg CM; McCracken GH; Culbertson MC
J Pediatr; 1976 Dec; 89(6):1011-3. PubMed ID: 792404
[TBL] [Abstract][Full Text] [Related]
18. [Passage into normal salivary, lacrimal and nasal secretions of ampicillin and erythromycin administered intramuscularly].
Melon J; Reginster M
Acta Otorhinolaryngol Belg; 1976; 30(6):643-51. PubMed ID: 1028340
[TBL] [Abstract][Full Text] [Related]
19. A comparison of blood levels after oral administration of erythromycin and erythromycin estolate.
GRIFFITH RS; BLACK HR
Antibiot Chemother (Northfield); 1962 Jun; 12():398-403. PubMed ID: 13901859
[No Abstract] [Full Text] [Related]
20. Antibiotic concentration in suction skin blister fluid and saliva after repeated dosage of erythromycin acistrate and erythromycin base.
Tuominen RK; Männistö PT; Solkinen A; Vuorela A; Pohto P; Haataja H
J Antimicrob Chemother; 1988 Jun; 21 Suppl D():57-65. PubMed ID: 3391876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
